Submitted by Anonymous (not verified) on 25 September 2026 - 14:02
Human medicines European public assessment report (EPAR): Incellipan, pandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures), Date of authorisation: 19/04/2024, Revision: 2, Status: Authorised
Source: